Nuvation Bio Inc.
NUVB
$6.22
$0.121.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -149.83M | -145.99M | -204.63M | -217.48M | -202.90M |
| Total Depreciation and Amortization | 2.15M | 1.97M | 1.74M | 1.42M | 1.05M |
| Total Amortization of Deferred Charges | 1.32M | 983.00K | 662.00K | 335.00K | 18.00K |
| Total Other Non-Cash Items | 57.34M | 43.55M | 40.78M | 38.18M | 32.46M |
| Change in Net Operating Assets | -31.49M | -26.24M | -11.98M | -12.45M | 1.18M |
| Cash from Operations | -120.52M | -125.73M | -173.43M | -190.00M | -168.19M |
| Capital Expenditure | -403.00K | -330.00K | -354.00K | -252.00K | -388.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -92.00K | -92.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.78M | 2.03M | 99.87M | 64.55M | 190.43M |
| Cash from Investing | -47.18M | 1.70M | 99.52M | 64.21M | 189.95M |
| Total Debt Issued | 254.95M | 210.10M | 210.10M | 204.48M | 204.48M |
| Total Debt Repaid | -72.26M | -12.72M | -12.39M | -8.40M | -11.54M |
| Issuance of Common Stock | 14.70M | 11.25M | 11.42M | 4.09M | 5.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.25M | -6.60M | -6.60M | -6.60M | -6.61M |
| Cash from Financing | 179.14M | 202.03M | 202.54M | 193.57M | 191.53M |
| Foreign Exchange rate Adjustments | -798.00K | -588.00K | -265.00K | 1.08M | 398.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.63M | 77.41M | 128.36M | 68.86M | 213.69M |